The active pharmaceutical ingredients market in Europe accounted for revenue of $19,868.39m in 2005, which grew at a compound annual growth rate (CAGR) of 4.8% to $26 billion in 2011.
The active pharmaceutical ingredients market is expected to increase further at a CAGR of 6.5% to reach $38 billion by 2017. Market growth is expected to be supported by healthy demand from the generic and biotech active pharmaceutical ingredients sectors.
Active pharmaceutical ingredients of good quality are core to the manufacturing of effective and safe essential drugs. The price of active pharmaceutical ingredients is the main cost driver for manufacturing.
Leading the way in the active pharmaceutical ingredients market is TAPI, the leading international supplier of active pharmaceutical ingredients with the industry's broadest portfolio of 300 products and over $747 million in annual third-party sales.
The European active pharmaceutical ingredients market accounted for around 24.2% of the global active pharmaceutical ingredients market revenue of $108.6 billion in 2011. Germany and France were the market leaders, with Italy and the UK trailing in third and fourth.
The remaining shares of the active pharmaceutical ingredients market depict the emergence of contract manufacturing organisation (CMO) activity and improvement in GDP in Central and Eastern European economies, which have driven up the health care market during recent years.
For more information on the active pharmaceutical ingredients market, see the latest research: Active Pharmaceutical Ingredients Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.